tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Paul Knight, 123 are a BUY (88.49%), 16 are a HOLD (11.51%).
Analyst Paul Knight, currently employed at KEYBANK, carries an average stock price target met ratio of 55.94% that have a potential upside of 36.92% achieved within 161 days.
Paul Knight’s has documented 274 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials sectors.
Most recent stock forecast was given on TMO, Thermo Fisher Scientific at 08-Dec-2025.
Analyst best performing recommendations are on OCX (ONCOCYTE CORP).
The best stock recommendation documented was for CYRX (CRYOPORT) at 1/19/2021. The price target of $75 was fulfilled within 3 days with a profit of $10.82 (16.86%) receiving and performance score of 56.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Aug-2023
$160
$26.15 (19.54%)
$140
27 days ago
(05-Jan-2026)
6/7 (85.71%)
$22.05 (15.98%)
38
Hold Since 10-Feb-2025
$165
$31.15 (23.27%)
$165
1 months 17 days ago
(15-Dec-2025)
16/18 (88.89%)
$25.32 (18.13%)
123
Hold Since 15-Dec-2025
$165
$31.15 (23.27%)
$125
1 months 17 days ago
(15-Dec-2025)
12/13 (92.31%)
$25.32 (18.13%)
164
Buy Since 15-Sep-2025
$175
$41.15 (30.74%)
$150
2 months 7 days ago
(25-Nov-2025)
16/21 (76.19%)
$21.4 (13.93%)
346
Buy Since 15-May-2018
$165
$31.15 (23.27%)
$136
2 months 7 days ago
(25-Nov-2025)
9/15 (60%)
$11.4 (7.42%)
112
Which stock is Paul Knight is most bullish on?
Which stock is Paul Knight is most reserved on?
What Year was the first public recommendation made by Paul Knight?
